Your first visit is a consultation. We review what has and hasn’t worked, your medications and your imaging, then plan the steps toward a correct diagnosis. We do not prescribe controlled substances, such as opioids, at the first visit.

Refer a
Patient

Your first visit is a consultation. We review what has and hasn’t worked, your medications and your imaging, then plan the steps toward a correct diagnosis. We do not prescribe controlled substances, such as opioids, at the first visit.

Facing an Amputation
If you have been told the circulation in your leg cannot be repaired, and that amputation is the remaining option, there is one more thing worth asking about. It will not be right for everyone, and it works better the earlier it is considered.
Home » Facing an Amputation

We start with the diagnosis

We do not decide on our own whether your leg can be reconstructed. That is a vascular surgeon’s call, and if you have not had that assessment, or it was some time ago, that comes first and we will arrange it.

If reconstruction genuinely is off the table, we talk through whether stimulation is reasonable for your stage of disease — including when the honest answer is that it is probably too late to help much. A trial comes before any permanent implant, so you find out whether it does anything for you before anything is implanted for good.

Who this page is for

People with advanced peripheral artery disease — sometimes called critical limb ischemia or chronic limb-threatening ischemia — who have reached the point where bypass surgery and stenting are no longer options. Either they have been tried and did not hold, or the disease is in a pattern that cannot be reconstructed.

At that stage the usual path is pain control and, eventually, amputation. Spinal cord stimulation is a third option, and it is not widely offered.

What the evidence actually shows

We are putting the numbers on this page rather than summarising them, because a decision this size should not be made on a practice’s adjectives.

What the research shows — limb salvage with spinal cord stimulation
  • Cochrane review — six trials, nearly 450 patients (Ubbink and Vermeulen, Cochrane Database of Systematic Reviews, 2013). Spinal cord stimulation added to conservative care, versus conservative care alone. Limb salvage at 12 months was significantly better with stimulation: risk ratio 0.71 (95% confidence interval 0.56 to 0.90). Significantly more patients improved to a less severe disease stage: risk ratio 4.9 (95% CI 2.0 to 11.9). Pain improved in both groups, more so with stimulation, and those patients needed significantly less pain medication. Ulcer healing showed no significant difference between the two.
  • A 53-patient centre experience, published February 2026 (Ouerchefani, Goldberg and Desgranges, Journal of Clinical Medicine). Patients implanted 2013–2022, followed two years. Pain scores fell from 9.4 to 3.7 out of 10. Walking distance rose from 70 metres to 429 metres. Limb survival at 12 months: 90% in the earlier disease stages, 70% in the most advanced stage. No major complications reported in this group. The authors’ own conclusion is that it may reduce the risk of major amputation, particularly when done at an earlier stage.
  • A 13-patient diabetic cohort, published December 2024 (Cyrek and colleagues, Frontiers in Surgery). All patients ineligible for surgical or interventional treatment. Limb salvage at one year: 92.3%. Ulcers healed in 75%. Over longer follow-up, 31% still went on to a major amputation — all of them in the most advanced disease stage. Ankle-brachial index was unchanged by the treatment.

What it costs you in risk. This is not a free option, and we are not going to present it as one.

In the Cochrane data the overall complication rate was 17% (95% CI 12 to 22). Problems at implantation occurred in 9%. Fifteen per cent needed a further procedure because the stimulation changed. Infection at the lead or the pocket occurred in 3%. Put plainly: for roughly every six people treated, one had a complication. The review’s authors concluded that the benefit for limb salvage has to be weighed against those complications and against the cost — and we agree with them.

What the evidence does not show is any effect on ulcer healing, or any change in the ankle-brachial index. It is not restoring the circulation. That is a different claim and nobody has made it.

What we do

Spinal cord stimulation

A trial first, then a permanent implant only if the trial helps you.

Spinal cord stimulation →

on cost

This is covered by most plans for this indication. We confirm your own coverage before anything is scheduled, and we tell you what we find either way.

For referring physicians

vascular surgery, podiatry, endocrinology and wound care

If you have a patient with non-reconstructable chronic limb-threatening ischemia and disabling rest pain, we are happy to see them, and happy to tell you when we do not think stimulation is worth it.

Earlier is better. The 2026 series found limb survival of 90% in Fontaine IIb/III against 70% in stage IV at twelve months. The patients sent to us after tissue loss is established do considerably worse than the ones sent before.

Refer a patient →

Ask the question before the decision is made

If an amputation has been raised with you, it is worth one consultation to find out whether this applies to you. Sometimes the answer will be no.

Bring us what has already been tried

Your first visit is a consultation. We go through what has and has not worked, your medications and your imaging, and plan the steps toward a correct diagnosis.

Schedule a consultation